Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
210 participants
OBSERVATIONAL
2023-11-12
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To determine the validity and reliability of cross cultural adapted and Urdu translated MLHFQ questionnaire version among HF patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urdu Translation of Duke Activity Status
NCT04739163
UrduTranslation And Validation Of The Pelvic Floor Distress Inventory Short Form (PFDI-20)
NCT04981873
Cardiovascular Disease Prevention Strategies for High-risk Urban Sedentary Employees in Karachi, Pakistan
NCT06981247
Reliability and Validity of Urdu Version of the King's Health Questionnaire
NCT06189469
ImpleMEntation of a Digital-first Care deLiverY Model for Heart Failure in Uganda
NCT05955937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Who could read and write in Urdu and English language and are willing to participate in the study.
Exclusion Criteria
* Communication barriers or cognitive disorder as well as those with exacerbated condition and those who were not available for re-test were excluded from the study.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammad Iqbal Tariq, PhD*
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Arshad Nawaz Malik, PhD
Role: STUDY_CHAIR
Riphah International University
Shane Patman, PhD
Role: STUDY_CHAIR
University of Notre Dame Australia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Railway General Hospital
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/PhD/01199 Iqbal Project B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.